The Enterprise Value as of December 2025 (TTM) for Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) is 12.61B

According to Tibet Rhodiola Pharmaceutical Holding Co.’s latest financial reports and current stock price. The company's current Enterprise Value is 12.61B. This represents a change of 10.46% compared to the average of 11.42B of the last 4 quarters.

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) Historical Enterprise Value (quarterly & annually)

How has 600211.SS Enterprise Value performed in the past?

The mean historical Enterprise Value of Tibet Rhodiola Pharmaceutical Holding Co. over the last ten years is 7.16B. The current 12.61B Enterprise Value has changed 17.50% with respect to the historical average. Over the past ten years (40 quarters), 600211.SS's Enterprise Value was at its highest in in the September 2020 quarter at 18.29B. The Enterprise Value was at its lowest in in the March 2020 quarter at 2.64B.

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Tibet Rhodiola Pharmaceutical Holding Co. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) Average Enterprise Value

How has 600211.SS Enterprise Value performed in the past?

The current Enterprise Value of Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) Enterprise Value vs. Peers

How is 600211.SS’s Enterprise Value compared to its peers?

Tibet Rhodiola Pharmaceutical Holding Co.’s Enterprise Value is greater than Shanghai Shyndec Pharmaceutical Co., Ltd. (10.93B), greater than Zhejiang Medicine Co., Ltd. (11.50B), less than Jiang Zhong Pharmaceutical Co.,Ltd (14.09B), less than Pacific Shuanglin Bio-pharmacy Co., Ltd. (13.27B), less than Zhejiang Jingxin Pharmaceutical Co., Ltd. (16.42B), greater than Henan Lingrui Pharmaceutical Co., Ltd. (12.23B), less than Guobang Pharma Ltd. (13.09B), less than Nanjing King-Friend Biochemical Pharmaceutical Co., Ltd (16.16B), less than Tibet Cheezheng Tibetan Medicine Co., Ltd. (13.75B), greater than Mayinglong Pharmaceutical Group Co., Ltd. (11.46B),

Build a custom stock screener for Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Tibet Rhodiola Pharmaceutical Holding Co. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Tibet Rhodiola Pharmaceutical Holding Co. (600211.SS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Tibet Rhodiola Pharmaceutical Holding Co. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.